[DOI] [PMC free article] [PubMed] [Google Scholar] 54.Rosetti B, Kralj S, Scarel E, Adorinni S, Rossi B, Vargiu AV
Its a great option for those wanting the benefits of HGH therapy, but in a gentler, more natural way
Fujiwara, A
Clinical experience: Nasal glucagon (Baqsimi) is feasible for rescue indications, with bioavailability of approximately 30%40%, rapid onset suitable for hypoglycemia rescue, and needle-free administration important for caregivers treating unconscious patients ( Best fit: Very potent peptides requiring small doses, rescue medications where needle-free administration is valuable (hypoglycemia, opioid overdose), or CNS-targeted strategies where direct nose-to-brain access may offer advantages over systemic administration
As more trial data accumulates and as the compound attracts more attention, the variance between supplier quality will become more consequential